Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangyin High-tech Zone Investment Group is a state-owned enterprise responsible for the investment, construction, and operation of the Jiangyin High-tech Industrial Development Zone in Jiangsu Province, China. The group plays a pivotal role in the regional life sciences sector by managing the Jiangyin High-tech Zone Biomedical Park, which serves as a major hub for pharmaceutical manufacturing and biotechnology research. It provides infrastructure, venture capital, and incubation services to a wide array of companies specializing in modern Chinese medicine, radiopharmaceuticals, and medical devices. Notable tenants and partners within its ecosystem include Tianjiang Pharmaceutical and various international CDMOs. The group acts as a strategic platform to foster innovation and industrial scaling within the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangyin Hi-tech Group.